Regnault, Antoine http://orcid.org/0000-0001-8234-2896
Pompilus, Farrah
Ciesluk, Anna
Mazerolle, Flora
Bejar, Rafael
Fram, Robert J.
Faller, Douglas V.
Marquis, Patrick
Bell, Jill A.
Funding for this research was provided by:
Millennium Pharmaceuticals, Inc., Cambridge, MA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited (Not applicable)
Article History
Received: 13 November 2020
Accepted: 29 June 2021
First Online: 20 July 2021
Declarations
:
: All study documents and procedures were approved by an independent institutional review board. Patients provided written consent to participate.
: All patients provided written consent to have the results of this study published in medical journals. The consent form informed patients that no personal information will be revealed.
: The study was funded by Millennium Pharmaceuticals, Inc., Cambridge, MA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited. JB, RF and DF are employees of and have ownership interest in Takeda Pharmaceuticals. AR, FP, AC, FM and PM are employees of Modus Outcomes, which received payment from Takeda Pharmaceuticals to conduct this research. RB declares employment and equity with Aptose Biosciences.